| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.27 | 5e-08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |